EGFR mutation and non-small-cell lung cancer: EGFR test, cost and quality of life

被引：0
|
作者：
Thongprasert, Sumitra [1 ]
机构：
[1] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand
来源：
LUNG CANCER MANAGEMENT | 2012年 / 1卷 / 03期
关键词：
D O I：
10.2217/LMT.12.34
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：169 / 172
页数：4
相关论文
共 50 条
  • [21] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, Jian
    Kane, Susan
    Wu, Jiong
    Benedettini, Elisa
    Li, Daiqiang
    Reeves, Cynthia
    Innocenti, Gregory
    Wetzel, Randy
    Crosby, Katherine
    Becker, Alison
    Ferrante, Michelle
    Cheung, Wan Cheung
    Hong, Xiqiang
    Chirieac, Lucian R.
    Sholl, Lynette M.
    Haack, Herbert
    Smith, Bradley L.
    Polakiewicz, Roberto D.
    Tan, Yi
    Gu, Ting-Lei
    Loda, Massimo
    Zhou, Xinmin
    Comb, Michael J.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3023 - 3028
  • [22] Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancer
    Carlisle, Jennifer W.
    Ramalingam, Suresh S.
    [J]. FUTURE ONCOLOGY, 2019, 15 (08) : 805 - 816
  • [23] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
  • [24] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer
    Giaccone, G
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 296 - 297
  • [25] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    [J]. MODERN PATHOLOGY, 2009, 22 : 364A - 364A
  • [27] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [28] Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer
    Kimura, Hideharu
    Ohira, Tatsuo
    Uchida, Osamu
    Matsubayashi, Jun
    Shimizu, Shinichiro
    Nagao, Toshitaka
    Ikeda, Norihiko
    Nishio, Kazuto
    [J]. LUNG CANCER, 2014, 83 (03) : 329 - 333
  • [29] EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer
    Toshihiko, Yokoyama
    Kondo, Masashi
    Goto, Yasuhiro
    Fukui, Takayuki
    Yoshioka, Hiromu
    Yokoi, Kohei
    Kondo, Yutaka
    Osada, Hirotaka
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Sekido, Yoshitaka
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [30] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 364A - 364A
12345